Beta Bionics shares slide after pricing underwritten public offering
Beta Bionics priced an underwritten public offering, and the stock fell 5.8% to $18.11 in premarket trading Wednesday after being down 37% for the year at Tuesday’s close.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.